FIELD: medicine, oncological urology.
SUBSTANCE: in pre-operational period one should detect patient's age, the availability of severe concomitant pulmonary pathology, clinical stage of tumor, intergrowth of prostatic capsule in case of finger-type rectal investigation, tumor localization in prostatic central area at ultrasound testing, intergrowth of prostatic capsule at ultrasound investigation, if a patient has got the closest relatives suffering with prostatic cancer or if a patient has got the closest relatives suffering with the cancer of another localization. It is necessary to calculate the value for the risk of local relapse by the following formula: R=-(0.046xAGE)+(1.01xCONCOMIT)+0.45x(CLIN T)+(1.78xPERRECT)+(0.65xTRUSI 1)+(0.74xTRUSI 2)+(0.87xRELATIV 1)+(0.05xRELATIV 2), where AGE - patient's age (yr); CONCOMIT - the availability of severe concomitant pulmonary pathology: 0 -yes, 1 - no; CLIN T - clinical stage of tumor: 1 -T1, 2 -T2, 3 - T3; PERRECT - intergrowth of prostatic capsule in case of finger-type rectal investigation: 0 - no, 1 - yes; TRUSI 1 - localization of prostatic tumor in prostatic central area in case of trans-rectal ultrasound investigation: 0 - no, 1 - yes; TRUSI 2 - intergrowth of prostatic capsule in case of trans-rectal investigation : 0 - no, 1 - yes; RELATIV 1 - if a patient has got the closest relatives suffering with prostatic cancer: 0 - no, 1 -yes; RELATIV 2 - if a patient has got the closest relatives suffering with cancer of another localization: 0 - no, 1 - yes. At values being R>0 one should predict the risk of local; relapse during 5 years. The innovation enables to carry out complex evaluation of the most informative risk factors of local relapse of prostatic tumor at pre-operational stage after radical prostatectomy in digital equivalent by taking into account individual clinical value of each risk factor.
EFFECT: higher efficiency and accuracy of prediction.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF BIOCHEMICAL RECURRENT IN PROSTATE CANCER PATIENTS AFTER RADIATION AND HORMONE THERAPY | 2015 |
|
RU2605838C1 |
METHOD FOR PREDICTING LOCAL RELAPSE OF PROSTATIC TUMOR AFTER RADICAL PROSTATECTOMY | 2004 |
|
RU2275841C1 |
METHOD FOR PREDICTING REMOTE METASTASES AFTER RADICAL PROSTATECTOMY IN PROSTATE CARCINOMA PATIENTS | 2005 |
|
RU2284758C1 |
METHOD FOR PREDICTING LOCAL PROSTATE RECURRENT TUMOR CASES AFTER HAVING DONE RADICAL PROSTATECTOMY | 2004 |
|
RU2274416C1 |
METHOD FOR DETERMINING INDICATIONS TO RADICAL PROSTATECTOMY IN PROSTATE CANCER | 2014 |
|
RU2549020C1 |
METHOD OF FORECASTING FIVE YEARS' RELAPSE-FREE SURVIVAL VALUE OF SICK WITH CANCER OF PROSTATE AFTER RADICAL PROSTATECTOMY | 2008 |
|
RU2351285C1 |
METHOD FOR PREOPERATIVE DETERMINATION OF MORPHOLOGICAL RISK FACTORS FOR PROGRESSION IN PATIENTS WITH PROSTATE CANCER | 2021 |
|
RU2770983C1 |
METHOD OF SELECTING PATIENTS WITH RECURRENT PROSTATE CANCER AFTER LOW-DOSE BRACHYTHERAPY FOR TREATING TRANSRECTAL HIGH-INTENSITY FOCUSED ULTRASOUND | 2019 |
|
RU2735656C1 |
METHOD FOR DETECTING LOCAL PROSTATE CARCINOMA RECURRENCE AFTER RADICAL PROSTATECTOMY | 2003 |
|
RU2224463C1 |
METHOD FOR EXTRAPROSTATIC EXTENSION FORECASTING OF PATIENTS WITH PROSTATE CANCER | 2007 |
|
RU2336826C1 |
Authors
Dates
2006-05-10—Published
2004-11-09—Filed